a
Biotechnology company Arteriocyte has received approval from the Food and Drug Administration to initiate a Phase I clinical trial with its Magellan MAR01 technology for treating compartment syndrome in extremity trauma patients.
Published in
Spine and Orthopedic Devices and Implants
Robert LaPrade, MD, a knee surgeon at The Steadman Clinic and chief medical research officer for the Steadman Philippon Research Institute in Vail, Colo., hosted and co-chaired the Biologic Treatments for Sports Injuries Symposium in early March.
Published in
Orthopedic Sports Medicine
February 21, 2012
PRP Could Enhance Healing in Nonunion Long-Bone Fractures
A recent study conducted in India showed that platelet-rich plasma can enhance the rate of union among patients with non-united long bone fractures, according to an AAOS Now report.
Published in
Orthopedic Sports Medicine
February 13, 2012
PRP May Benefit Athletes With Partial UCL Tears
Orthopedic surgeons and researchers found that platelet-rich plasma can produce improvement in patients who suffer from elbow injury after conservative treatments fail, according to a news release from the American Orthopaedic Society for Sports Medicine.
Published in
Orthopedic Sports Medicine
February 07, 2012
CONMED Launches 6 Sports Medicine Devices
CONMED has announced it will launch several new sports medicine devices over the next week, according to a company news release.
Published in
Spine and Orthopedic Devices and Implants
January 20, 2012
AAOS Adds PRP Symposium to Annual Meeting
The American Academy of Orthopaedic Surgeons has added a new annual meeting symposium titled "Should I Use Platelet-Rich Plasma for My Patients in the Office and Operating Room?," according to an organization report.
Published in
Orthopedic Sports Medicine
January 11, 2012
Arthrex Partners With ThermoGenesis for PRP System Distribution
ThermoGenesis, a Rancho Cordova, Calif.-based medical device company, recently partnered with Arthrex to market the ThermoGenesis Res-Q 60 System for preparing autologous platelet-rich plasma and bone marrow concentrate, according to a company news release.
Published in
Spine and Orthopedic Devices and Implants
Wayne, N.J.-based medical device company Cascade Medical Enterprises has sold its technology for platelet-rich plasma and platelet-rich fibrin matrix to Musculoskeletal Transplant Foundation, according to a Cascade Medical news release.
Published in
Spine and Orthopedic Devices and Implants
December 29, 2011
11 Points on Technology & Treatment Revolutionizing Sports Medicine
Top sports medicine physicians and specialists discuss the most important technology and techniques revolutionizing their practices today and where sports medicine is headed in the future.
Published in
Orthopedic Sports Medicine
October 28, 2011
Where Does PRP Fit? 5 Studies on Outcomes
Here are five studies examining the effectiveness of platelet-rich plasma in different applications. The studies were all published in the American Journal of Sports Medicine unless otherwise noted.
Published in
Orthopedic Sports Medicine




